Onco-Innovations Limited (NEO:ONCO)

Onco-Innovations Balance Sheet

Financials in millions CAD. Fiscal year is May - April.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023
Cash & Equivalents	1.11	0.45	0.02
Cash & Short-Term Investments	1.11	0.45	0.02
Cash Growth	148.24%	2318.62%	-
Accounts Receivable	0.05	-	-
Other Receivables	0.04	-	-
Receivables	0.09	-	-
Prepaid Expenses	1.01	-	-
Total Current Assets	2.22	0.45	0.02
Total Assets	2.22	0.45	0.02
Accounts Payable	0.38	0.09	-
Accrued Expenses	0.03	0.04	-
Total Current Liabilities	0.41	0.13	-
Total Liabilities	0.41	0.13	-
Common Stock	8.68	0.05	0
Retained Earnings	-8.63	-0.13	-0
Comprehensive Income & Other	1.75	0.4	0.02
Shareholders' Equity	1.81	0.32	0.02
Total Liabilities & Equity	2.22	0.45	0.02
Net Cash (Debt)	1.11	0.45	0.02
Net Cash Growth	148.24%	2318.62%	-
Net Cash Per Share	0.03	0.13	-
Filing Date Shares Outstanding	53.83	38.38	-
Total Common Shares Outstanding	50.71	4.38	-
Working Capital	1.81	0.32	0.02
Book Value Per Share	0.04	0.07	-
Tangible Book Value	1.81	0.32	0.02
Tangible Book Value Per Share	0.04	0.07	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.